Abstract
Poly(DL-lactide-co-RS-hydroxyethyl-beta-malolactonate) (PLMAH), a novel functionalized polylactide with hydroxyl arms, was synthesized by a two-step reaction. DL-lactide (DLLA) and RS-benzyloxyethyl-beta-malolactonate were first copolymerized by ring-opening polymerization with Sn(Oct)(2) as catalyst to generate poly(DL-lactide-co-RS-benzyloxyethyl-beta-malolactonate) (PLMAB); next the benzyl protective groups of PLMAB were removed by the hydrogenation reaction catalyzed by Pd/C to generate the final polymer PLMAH. The composition and structure of PLMAB and PLMAH were characterized by (1)H and (13)C NMR. In vitro degradation experiments of PLMAH copolymers showed that the more RS-hydroxyethyl-beta-malolactonate (MAHE) content in the copolymer film, the faster the degradation occurred. The results of human umbilical vein endothelial cells (ECV-304) cultivated on PDLLA and PLMAH films suggested that among all the films, the PLMAH film containing 9.4 mol % MAHE had the highest cell attachment efficiency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
